Golf Rounds.com (OTCMKTS:FZMD) & Becton, Dickinson and Company (NYSE:BDX) Financial Survey

Golf Rounds.com (OTCMKTS:FZMD) and Becton, Dickinson and Company (NYSE:BDX) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, profitability, earnings, analyst recommendations, institutional ownership, dividends and valuation.

Analyst Recommendations

This is a summary of current recommendations and price targets for Golf Rounds.com and Becton, Dickinson and Company, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Golf Rounds.com	0	0	0	0	0.00
Becton, Dickinson and Company	0	9	4	0	2.31

Becton, Dickinson and Company has a consensus price target of $205.64, indicating a potential upside of 4.79%. Given Becton, Dickinson and Company’s stronger consensus rating and higher probable upside, analysts clearly believe Becton, Dickinson and Company is more favorable than Golf Rounds.com.

Valuation & Earnings

This table compares Golf Rounds.com and Becton, Dickinson and Company”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Golf Rounds.com	$10.73 million	N/A	$510,000.00	N/A	N/A
Becton, Dickinson and Company	$21.84 billion	2.56	$1.68 billion	$5.83	33.66

Becton, Dickinson and Company has higher revenue and earnings than Golf Rounds.com.

Institutional & Insider Ownership

87.0% of Becton, Dickinson and Company shares are held by institutional investors. 92.3% of Golf Rounds.com shares are held by insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Golf Rounds.com and Becton, Dickinson and Company’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Golf Rounds.com	N/A	N/A	N/A
Becton, Dickinson and Company	7.68%	16.42%	7.58%

Risk & Volatility

Golf Rounds.com has a beta of -0.82, suggesting that its share price is 182% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.25, suggesting that its share price is 75% less volatile than the S&P 500.

Summary

Becton, Dickinson and Company beats Golf Rounds.com on 10 of the 11 factors compared between the two stocks.

About Golf Rounds.com

Fuse Medical, Inc. manufactures and distributes medical devices in the United States. The company offers orthopedic implants, including internal and external fixation products for foot and ankle; upper and lower extremity plating and total joint reconstruction implants; soft tissue fixation and augmentation for sports medicine procedures; and full spinal implants for trauma, degenerative disc disease, and deformity indications. It also provides osteo-biologics and regenerative products, which include human allografts, tendons, synthetic skin and bone substitute materials, and regenerative tissues. The company serves hospitals, medical facilities, and sub-distributors. Fuse Medical, Inc. is based in Richardson, Texas.

About Becton, Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.